Real-world efficacy and safety of lenvatinib: data from a compassionate use in the treatment of radioactive iodinerefractory differentiated thyroid cancer patients in Italy

L. D. Locati; A Piovesan; C. Durante; M. Bregni; M.G. Castagna; S. Zovato; M. Giusti; Toni Ibrahim; E. Puxeddu

Real-world efficacy and safety of lenvatinib: data from a compassionate use in the treatment of radioactive iodinerefractory differentiated thyroid cancer patients in Italy

L. D. Locati, A Piovesan, C. Durante, M. Bregni, M.G. Castagna, S. Zovato, M. Giusti, Toni Ibrahim, E. Puxeddu

Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	35-40
Journal	European Journal of Cancer
Publication status	Published - 2019

Cite this

@article{c34ff9bdbc8a4eb08999a358a3877183,

title = "Real-world efficacy and safety of lenvatinib: data from a compassionate use in the treatment of radioactive iodinerefractory differentiated thyroid cancer patients in Italy",

author = "Locati, {L. D.} and A Piovesan and C. Durante and M. Bregni and M.G. Castagna and S. Zovato and M. Giusti and Toni Ibrahim and E. Puxeddu",

year = "2019",

language = "English",

pages = "35--40",

journal = "European Journal of Cancer",

issn = "0014-2964",

publisher = "Elsevier Ltd",

}

TY - JOUR

T1 - Real-world efficacy and safety of lenvatinib: data from a compassionate use in the treatment of radioactive iodinerefractory differentiated thyroid cancer patients in Italy

AU - Locati, L. D.

AU - Piovesan, A

AU - Durante, C.

AU - Bregni, M.

AU - Castagna, M.G.

AU - Zovato, S.

AU - Giusti, M.

AU - Ibrahim, Toni

AU - Puxeddu, E.

PY - 2019

Y1 - 2019

M3 - Article

SP - 35

EP - 40

JO - European Journal of Cancer

JF - European Journal of Cancer

SN - 0014-2964

ER -